Oken A, Ditter I, Lisi N, Krishnamurthy I, Godsey M, Mansoor S
Sci Adv. 2024; 10(40):eado5084.
PMID: 39365862
PMC: 11451537.
DOI: 10.1126/sciadv.ado5084.
Oken A, Lisi N, Krishnamurthy I, McCarthy A, Godsey M, Glasfeld A
Nat Commun. 2024; 15(1):6662.
PMID: 39107314
PMC: 11303814.
DOI: 10.1038/s41467-024-50771-6.
Longo Y, Moreno Mascaraque S, Andreacchio G, Werner J, Katahira I, De Marchi E
Front Immunol. 2024; 15:1360140.
PMID: 38711513
PMC: 11070468.
DOI: 10.3389/fimmu.2024.1360140.
Wang W, Zhang H, Sandai D, Zhao R, Bai J, Wang Y
Front Cell Dev Biol. 2024; 11:1324213.
PMID: 38161333
PMC: 10755924.
DOI: 10.3389/fcell.2023.1324213.
Schafer W, Stahler T, Pinto Espinoza C, Danquah W, Knop J, Rissiek B
Front Pharmacol. 2022; 13:1033135.
PMID: 36467077
PMC: 9715982.
DOI: 10.3389/fphar.2022.1033135.
Mechanical Disturbance of Osteoclasts Induces ATP Release That Leads to Protein Synthesis in Skeletal Muscle through an Akt-mTOR Signaling Pathway.
Morales-Jimenez C, Balanta-Melo J, Arias-Calderon M, Hernandez N, Gomez-Valenzuela F, Escobar A
Int J Mol Sci. 2022; 23(16).
PMID: 36012713
PMC: 9408906.
DOI: 10.3390/ijms23169444.
Platelet-Rich Fibrin Reduces IL-1β Release from Macrophages Undergoing Pyroptosis.
Sordi M, Panahipour L, Kargarpour Z, Gruber R
Int J Mol Sci. 2022; 23(15).
PMID: 35955441
PMC: 9368224.
DOI: 10.3390/ijms23158306.
P2X7 receptor is essential for cross-dressing of bone marrow-derived dendritic cells.
Barrera-Avalos C, Briceno P, Valdes D, Imarai M, Leiva-Salcedo E, Rojo L
iScience. 2021; 24(12):103520.
PMID: 34950860
PMC: 8671947.
DOI: 10.1016/j.isci.2021.103520.
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.
Hasan D, Shono A, van Kalken C, van der Spek P, Krenning E, Kotani T
Purinergic Signal. 2021; 18(1):13-59.
PMID: 34757513
PMC: 8578920.
DOI: 10.1007/s11302-021-09814-6.
Upregulation of the P2X7 receptor promotes Ca accumulation and inflammatory response in post-stroke depression.
Shen L, Wang Z, Wang R, Chen X, Cheng S
Am J Transl Res. 2021; 13(9):10276-10287.
PMID: 34650696
PMC: 8507060.
Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?.
Collado-Diaz V, Martinez-Cuesta M, Blanch-Ruiz M, Sanchez-Lopez A, Garcia-Martinez P, Peris J
Front Pharmacol. 2021; 12:613449.
PMID: 33867979
PMC: 8045785.
DOI: 10.3389/fphar.2021.613449.
Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor.
Martinez-Cuesta M, Blanch-Ruiz M, Ortega-Luna R, Sanchez-Lopez A, Alvarez A
Int J Mol Sci. 2020; 21(22).
PMID: 33182829
PMC: 7696479.
DOI: 10.3390/ijms21228454.
P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance.
Coccurello R, Volonte C
Front Endocrinol (Lausanne). 2020; 11:199.
PMID: 32528404
PMC: 7247848.
DOI: 10.3389/fendo.2020.00199.
P-Purinoceptors: Advances and therapeutic opportunities.
Williams M, Jacobson K
Expert Opin Investig Drugs. 2019; 4(10):925-934.
PMID: 31827369
PMC: 6905462.
DOI: 10.1517/13543784.4.10.925.
The Role of the P2X7 Receptor in Ocular Stresses: A Potential Therapeutic Target.
Dutot M, Olivier E, Wakx A, Rat P
Vision (Basel). 2019; 1(2).
PMID: 31740640
PMC: 6835678.
DOI: 10.3390/vision1020014.
Targeting the P2X7 Receptor in Age-Related Macular Degeneration.
Yang D
Vision (Basel). 2019; 1(2).
PMID: 31740637
PMC: 6836166.
DOI: 10.3390/vision1020011.
Blocking P2X7 receptor ameliorates oxidized LDL-mediated podocyte apoptosis.
Zhu Y, Li Q, Xun W, Chen Y, Zhang C, Sun S
Mol Biol Rep. 2019; 46(4):3809-3816.
PMID: 31004300
DOI: 10.1007/s11033-019-04823-6.
New Insights Into Permeation of Large Cations Through ATP-Gated P2X Receptors.
Peverini L, Beudez J, Dunning K, Chataigneau T, Grutter T
Front Mol Neurosci. 2018; 11:265.
PMID: 30108481
PMC: 6080412.
DOI: 10.3389/fnmol.2018.00265.
Genetic variation in P2RX7 and pain tolerance.
Kambur O, Kaunisto M, Winsvold B, Wilsgaard T, Stubhaug A, Zwart J
Pain. 2018; 159(6):1064-1073.
PMID: 29470314
PMC: 5965926.
DOI: 10.1097/j.pain.0000000000001188.
Pretreatment with quercetin prevents changes in lymphocytes E-NTPDase/E-ADA activities and cytokines secretion in hyperlipidemic rats.
Braun J, Ruchel J, Manzoni A, Abdalla F, Casalli E, Castilhos L
Mol Cell Biochem. 2017; 444(1-2):63-75.
PMID: 29188537
DOI: 10.1007/s11010-017-3231-6.